How mutations in DNMT3A affect blood cell development and disease progression
Integration of HSC Stress Responses and Disease Progression by DNMT3A Mutations
This study is looking at how certain changes in a gene called DNMT3A might help blood stem cells survive better during long-term inflammation, which could lead to blood-related illnesses, and it's being led by Dr. Christine Zhang, who wants to learn more about blood health and genetics while working with top experts in the field.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-11103614 on NIH RePORTER |
What this research studies
This research investigates the role of DNMT3A mutations in hematopoietic stem cells (HSC) and how these mutations may provide a fitness advantage during chronic inflammation, potentially leading to blood diseases. The principal investigator, Dr. Christine Zhang, aims to enhance her expertise in hematology and epigenetics while employing advanced techniques to analyze how these genetic changes impact blood cell formation and function. By collaborating with leading experts in the field, the research seeks to uncover the mechanisms behind defective hematopoiesis and its implications for disease progression.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with known DNMT3A mutations or those experiencing chronic inflammation related to blood disorders.
Not a fit: Patients without blood diseases or those not affected by DNMT3A mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with blood diseases linked to DNMT3A mutations.
How similar studies have performed: Previous research has shown promising results in understanding the role of genetic mutations in blood diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Chicago, UNITED STATES
- Northwestern University — Chicago, United States (Active)
Researchers
- Principal investigator: Zhang, Christine R — Northwestern University
- Study coordinator: Zhang, Christine R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.